How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lidocaine-hydrochloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Lignospan Forte — Competitive Intelligence Brief

Lignospan Forte (Lidocaine Hydrochloride) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: local anesthetic, amide type. Area: Neuroscience.

marketed local anesthetic, amide type neuronal membrane ionic channels Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Lignospan Forte (Lidocaine Hydrochloride) — Fresenius Kabi. Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Lignospan Forte TARGET	Lidocaine Hydrochloride	Fresenius Kabi	marketed	local anesthetic, amide type	neuronal membrane ionic channels	1948-01-01
Lignospan Forte	Lidocaine Hydrochloride	Fresenius Kabi	marketed	local anesthetic, amide type	neuronal membrane ionic channels	1948-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2026-07-24 — Lignospan Forte · 8759401 · Formulation · US
2029-10-22 — Lignospan Forte · 8540665 · Method of Use · US
2035-04-27 — Lignospan Forte · 9358338 · Method of Use · US
2035-09-28 — Lignospan Forte · 9370622 · Method of Use · US

Sponsor landscape (local anesthetic, amide type class)

Fresenius Kabi · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Lignospan Forte — Competitive Intelligence Brief. https://druglandscape.com/ci/lidocaine-hydrochloride. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab